SC 13G/A | 2021-02-12 | Allianz Global Investors U.S. Holdings LLC | Assertio Therapeutics, Inc | 0 | 0.0% | EDGAR |
SC 13D | 2020-03-26 | Assertio Therapeutics, Inc | Zyla Life Sciences | 4,854,863 | 51.0% | EDGAR |
SC 13G/A | 2020-02-14 | ARMISTICE CAPITAL, LLC | Assertio Therapeutics, Inc | 0 | 0.0% | EDGAR |
SC 13G/A | 2020-02-14 | D. E. SHAW & CO, L.P. | Assertio Therapeutics, Inc | 4,506,585 | 5.6% | EDGAR |
SC 13G/A | 2020-02-13 | RENAISSANCE TECHNOLOGIES LLC | Assertio Therapeutics, Inc | 6,529,527 | 8.1% | EDGAR |
SC 13G | 2020-02-13 | Allianz Global Investors U.S. Holdings LLC | Assertio Therapeutics, Inc | 5,911,875 | 7.3% | EDGAR |
SC 13G/A | 2020-02-12 | VANGUARD GROUP INC | Assertio Therapeutics, Inc | 5,152,682 | 6.4% | EDGAR |
SC 13G/A | 2020-02-12 | DIMENSIONAL FUND ADVISORS LP | Assertio Therapeutics, Inc | 3,919,354 | 4.9% | EDGAR |
SC 13G/A | 2020-01-10 | BlackRock Inc. | Assertio Therapeutics, Inc | 5,797,457 | 7.2% | EDGAR |
SC 13G | 2019-11-12 | D. E. SHAW & CO, L.P. | Assertio Therapeutics, Inc | 4,059,416 | 5.0% | EDGAR |
SC 13G/A | 2019-02-14 | ARMISTICE CAPITAL, LLC | Assertio Therapeutics, Inc | 3,278,000 | 5.1% | EDGAR |
SC 13G | 2019-02-12 | RENAISSANCE TECHNOLOGIES LLC | Assertio Therapeutics, Inc | 4,668,591 | 7.3% | EDGAR |
SC 13G/A | 2019-02-11 | VANGUARD GROUP INC | Assertio Therapeutics, Inc | 6,422,594 | 10.0% | EDGAR |
SC 13G/A | 2019-02-11 | VANGUARD GROUP INC | Assertio Therapeutics, Inc | 6,422,594 | 10.0% | EDGAR |
SC 13G/A | 2019-02-08 | Senvest Management, LLC | Assertio Therapeutics, Inc | 2,384,319 | 3.7% | EDGAR |
SC 13G/A | 2019-02-08 | VANGUARD GROUP INC | Assertio Therapeutics, Inc | 5,482,023 | 8.6% | EDGAR |
SC 13G | 2019-02-08 | DIMENSIONAL FUND ADVISORS LP | Assertio Therapeutics, Inc | 3,948,514 | 6.2% | EDGAR |
SC 13G | 2019-01-24 | BlackRock Inc. | Assertio Therapeutics, Inc | 10,400,542 | 16.3% | EDGAR |
SC 13D/A | 2018-05-22 | Starboard Value LP | DEPOMED INC | 2,703,995 | 4.3% | EDGAR |
SC 13D/A | 2018-05-14 | Starboard Value LP | DEPOMED INC | 3,885,295 | 6.1% | EDGAR |